Article abstract


Nature Medicine 13, 423 - 431 (2007)
Published online: 25 March 2007 | doi:10.1038/nm1564

Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation

Thomas Korn1, Jayagopala Reddy1, Wenda Gao2, Estelle Bettelli1, Amit Awasthi1, Troels R Petersen3, B Thomas Bäckström3, Raymond A Sobel4, Kai W Wucherpfennig5, Terry B Strom2, Mohamed Oukka1,6 & Vijay K Kuchroo1,6


Treatment with ex vivo–generated regulatory T cells (T-reg) has been regarded as a potentially attractive therapeutic approach for autoimmune diseases. However, the dynamics and function of T-reg in autoimmunity are not well understood. Thus, we developed Foxp3gfp knock-in (Foxp3gfp.KI) mice and myelin oligodendrocyte glycoprotein (MOG)35–55/IAb (MHC class II) tetramers to track autoantigen-specific effector T cells (T-eff) and T-reg in vivo during experimental autoimmune encephalomyelitis (EAE), an animal model for multiple sclerosis. MOG tetramer–reactive, Foxp3+ T-reg expanded in the peripheral lymphoid compartment and readily accumulated in the central nervous system (CNS), but did not prevent the onset of disease. Foxp3+ T cells isolated from the CNS were effective in suppressing naive MOG-specific T cells, but failed to control CNS-derived encephalitogenic T-eff that secreted interleukin (IL)-6 and tumor necrosis factor (TNF). Our data suggest that in order for CD4+Foxp3+ T-reg to effectively control autoimmune reactions in the target organ, it may also be necessary to control tissue inflammation.

Top
  1. Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
  2. Transplant Research Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02115, USA.
  3. Malaghan Institute of Medical Research, P.O. Box 7060, Wellington South, New Zealand.
  4. Laboratory Service, Veterans Affairs Health Care System, Palo Alto, California 94304, and Department of Pathology, Stanford University School of Medicine, Stanford, California 94305, USA.
  5. Department of Cancer Immunology & AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
  6. These authors contributed equally to this work.

Correspondence to: Mohamed Oukka1,6 e-mail: moukka@rics.bwh.harvard.edu

Correspondence to: Vijay K Kuchroo1,6 e-mail: vkuchroo@rics.bwh.harvard.edu



MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

T effectors outfox T regulators in autoimmunity

Nature Medicine News and Views (01 Apr 2007)

T effectors outfox T regulators in autoimmunity

Nature Medicine News and Views (01 Apr 2007)

See all 3 matches for News And Views

Extra navigation

Subscribe to Nature Medicine

Subscribe

Open Innovation Challenges

naturejobs

ADVERTISEMENT